Pulmonary hypertension: diagnostic and therapeutic challenges

Area of Science:

• Cardiology
• Pulmonology
• Pathophysiology

Background:

• Pulmonary hypertension (PH) is a complex hemodynamic condition.
• It presents with dyspnea, reduced exercise tolerance, and can lead to right heart failure.
• The World Health Organization classifies PH into five distinct groups.

Purpose of the Study:

• To provide an overview of the five groups of pulmonary hypertension (PH).
• To discuss the diagnostic challenges in identifying and classifying PH.
• To highlight the therapeutic challenges associated with different PH groups.

Main Methods:

• Review of the World Health Organization's classification of PH.
• Discussion of the pathophysiology of pulmonary arterial hypertension (PAH).
• Analysis of diagnostic tools like echocardiography and right heart catheterization.

Main Results:

• Pulmonary arterial hypertension (PAH) is one of five PH groups, often linked to endothelial dysfunction.
• Distinguishing PAH is crucial as specific treatments target its unique molecular pathways.
• Other PH groups include those related to left heart disease, lung disease, and chronic thromboembolic disease.
• Echocardiography is a screening tool, but right heart catheterization provides confirmatory data.
• Diagnosing and treating PH can be challenging, especially when cases overlap between groups.

Conclusions:

• Accurate classification of PH is essential for appropriate management.
• PAH requires specific therapies not suitable for other PH types.
• Diagnostic and therapeutic strategies for PH remain complex and challenging.